胃切除术与食管切除术治疗胃食管结合部肿瘤:荷兰上消化道肿瘤审计的短期与长期结局
本研究基于荷兰上消化道肿瘤审计前瞻性数据联合医保数据库,回顾性比较2011至2016年因胃食管结合部癌行全胃切除(81例)或食管切除(790例)患者的结局。两组3年总生存率、术后并发症、死亡率、切缘根治性、淋巴结检出数及3年条件生存均无显著差异。若两种术式均可行,制定手术方案时应考虑术者经验与生活质量等其他因素。
要点
- 胃食管结合部癌行全胃切除或食管切除,长期生存与短期结局基本相当。
- 两术式在并发症、死亡率、根治性及淋巴结检出数上未见显著差异。
- 两种术式均可行时,应结合术者经验与生活质量等因素决策。
核心结论
- 对胃食管结合部癌行全胃切除与食管切除,在长期生存、术后并发症、死亡率及病理结果方面大体相当。
- 若两种术式均可行,规划手术时应考虑术者经验与生活质量等其他参数。
研究设计与样本
- 回顾性比较队列研究,数据来自荷兰上消化道肿瘤审计前瞻性收集资料,联合荷兰医保数据库生存数据。
- 纳入2011至2016年因胃食管结合部癌行全胃切除或食管切除的患者,共871例,其中食管切除790例、胃切除81例。
- 主要终点为3年总生存,次要终点包括术后并发症、死亡率、3年条件生存、切缘根治性与淋巴结检出数。
主要发现
- 食管切除组3年总生存率为35.8%,胃切除组为28.4%(风险比1.2,95%置信区间0.721-1.836,P=0.557)。
- 术后并发症、死亡率、切缘根治性、淋巴结检出数及3年条件生存两组间均无显著差异。
临床怎么用
- 胃食管结合部癌选择全胃切除或食管切除时,可认为两种术式在肿瘤学与安全性结局上大体可比。
- 当两种术式均技术上可行时,应将术者经验与生活质量等因素纳入术式选择决策。
局限性
- 为回顾性比较队列研究,非随机分组,两组样本量差异明显(食管切除790例 vs 胃切除81例)。
- 数据来源于荷兰上消化道肿瘤审计与医保数据库,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Investigate long-term survival, morbidity, mortality, and pathology results in patients following esophagectomy or total gastrectomy for gastroesophageal junction (GEJ) cancer. BACKGROUND: Both a total gastrectomy and an esophagectomy may be valid treatment options in patients with GEJ cancer. Which procedure results in the most optimal patient outcome is not well studied. The aim of this study was to investigate the long-term survival, morbidity, mortality, and pathology results in patients following esophagectomy or total gastrectomy for GEJ cancer. METHODS: A retrospective comparative cohort study of prospectively collected data from the Dutch Upper GI Cancer Audit combined with survival data of the Dutch medical insurance database was performed. Patients with GEJ cancer in whom a total gastrectomy or an esophagectomy was performed between 2011 and 2016 were compared. The primary outcome was 3-year overall survival. Postoperative morbidity, mortality, 3-year conditional survival, radicality of resection, and lymph node yield were secondary endpoints. RESULTS: A total of 871 patients were included: 790 following esophagectomy and 81 following gastrectomy. The 3-year overall survival was 35.8% after esophagectomy and 28.4% after gastrectomy (hazard ratio 1.2, 95% confidence interval 0.721-1.836, P = 0.557). Postoperative morbidity, mortality, radicality of resection, lymph node yield, and 3-year conditional survival did not differ significantly between groups. CONCLUSION: A total gastrectomy and an esophagectomy for GEJ cancer show largely comparable results with regard to long-term survival, postoperative morbidity, mortality, and pathology results. If both procedures are feasible, other parameters such as surgeon's experience and quality of life should be considered when planning for surgery.
引用
- Jezerskyte E, Mertens AC, Dieren SV, et al. Gastrectomy Versus Esophagectomy for Gastroesophageal Junction Tumors: Short- and Long-Term Outcomes From the Dutch Upper Gastrointestinal Cancer Audit. Ann Surg. 2020. PMID: 33214453. doi:10.1097/SLA.0000000000004610
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。